How does Artemisia campestris work as a digestive aid?

Artemisia campestris works primarily as a carminative and bitter tonic. Its active compounds, including camphor and flavonoids, stimulate gastric secretions and help relax intestinal smooth muscle, which reduces spasms and relieves bloating. The bitter properties trigger the release of bile and digestive enzymes, facilitating the digestion of food. These mechanisms support its traditional use for digestive complaints, though clinical evidence remains limited (Evidence Level C).

Is Artemisia campestris safe to take during pregnancy?

No, Artemisia campestris is considered unsafe during pregnancy. The herb contains thujone and other volatile oils that may stimulate uterine contractions or cause fetal toxicity. Due to these emmenagogue properties and potential neurotoxicity, pregnant and breastfeeding women should strictly avoid this herb. Traditional contraindications explicitly list pregnancy as a condition to avoid use.

What is the recommended dosage for Artemisia campestris tea?

The standard adult dosage for Artemisia campestris is 2 to 4 grams of the dried herb prepared as an infusion (tea). This amount is typically taken up to three times daily to address digestive complaints. Users should not exceed this recommended dosage without consulting a qualified healthcare provider, as higher doses may increase the risk of adverse effects.

Does Artemisia campestris interact with any medications?

Artemisia campestris may interact with anticoagulant and anticonvulsant medications. The presence of flavonoids could potentiate the effects of blood thinners like warfarin, increasing bleeding risk. Additionally, the thujone content, though low, may lower the seizure threshold, potentially interfering with epilepsy medications. Patients taking these drugs should consult a physician before use (Evidence Level D).

What are the traditional uses of Artemisia campestris?

Traditionally, Artemisia campestris has been used in European and Asian folk medicine primarily as a digestive aid, carminative, and febrifuge. It is employed to relieve gas, bloating, and stomach cramps, as well as to reduce fever. The herb has also been utilized as an anthelmintic to expel intestinal parasites. These applications are supported by ethnobotanical history rather than extensive clinical trials (Evidence Level C).

Artemisia campestris (Artemisia campestris)

PubMed-compiled information sheet

This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.

Compiled from 30 PubMed articles · model: gemma4:31b

Summary

Artemisia campestris is a polymorphic species of the Asteraceae family recognized for its medicinal, pharmacological, and culinary properties [PMID:30551444]. It exhibits diverse biological activities, including antioxidant, anti-inflammatory, and antimicrobial effects [PMID:30551444, PMID:33932510].

Background

Artemisia campestris L. is a polymorphic species consisting of many subspecies and varieties, such as ssp. glutinosa and ssp. variabilis [PMID:30551444, PMID:17396957, PMID:36376619]. It is found in various regions including the Mediterranean littoral sands of Spain and Italy, Morocco, Tunisia, and Algeria [PMID:17396957, PMID:37019158, PMID:38698384, PMID:39918166].

Traditional uses

Traditionally used in the Mediterranean region as a medicinal plant [PMID:32758575], specifically in eastern Morocco for treating digestive system problems [PMID:37019158] and in Portugal for gastric disorders, rheumatism, and hypertension [PMID:33932510]. It is also used for the treatment of diabetes and hypertension [PMID:28578165].

Active compounds

Bioactive compounds include flavonoids such as sakuranetin, pinostrobin, pinocembrin, naringenin, hispidulin, apigenin, chrysin, eupatilin, and cirsiliol [PMID:35844107, PMID:17396957, PMID:42223488, PMID:29208178]. Essential oils are dominated by compounds such as beta-pinene, 2-undecanone, caryophyllene oxide, and curcumene [PMID:30389026, PMID:21299136, PMID:38472862]. Other identified components include caffeoylquinic acid isomers, benzoic acid derivatives, chlorogenic acid, and rutin [PMID:32454719, PMID:35460338].

Mechanism of action

In acute myeloid leukemia cells, ethyl acetate extract induces apoptosis by increasing DNA fragmentation, causing mitochondrial depolarization, and activating caspases 3/7 [PMID:39037595]. Flavonoids like apigenin, chrysin, and sakuranetin are suggested as potential FLT3 inhibitors [PMID:42223488]. The plant's essential oil may act via the muscarinic receptor and L-type voltage-gated Ca2+ channel to produce myorelaxant and antispasmodic effects [PMID:37019158]. Ethanolic extracts may inhibit HIV-1 replication by acting on viral entry and the NF-κB pathway [PMID:32758575].

Clinical evidence

Evidence DAcute Myeloid Leukemia (AML)

Ethyl acetate extract induced cell apoptosis in mononuclear cells from AML patients [PMID:39037595]

Evidence DGastroesophageal Reflux (GER)

Aqueous extract (100-400 mg/kg) significantly protected against macroscopic and histological injuries in rat esophagus [PMID:29306510]

Evidence DHypertension

Aqueous extract demonstrated antihypertensive and hypotensive effects in rats [PMID:28578165]

Evidence DPolycystic Ovarian Syndrome (PCOS)

Oral administration of extract (200 mg/kg) significantly reduced LH levels in rats [PMID:39462196]

Evidence DObesity

n-butanol fraction of methanolic leaf extract reduced oxidative stress in the liver of high-fat diet rats [PMID:35460338]

Evidence DChlorpyrifos-induced organ injury

Essential oil alleviated biochemical disruptions and reduced hepato-renal morphologic changes in rats [PMID:33716767]

Safety & adverse effects

Toxicity tests using brine shrimp (Artemia sp.) assay showed LC50 values ranging to 20 microg/mL for some oils [PMID:21299136].

Evidence summary

The current evidence is primarily based on in vitro studies, in silico modeling, and animal models (rats/mice), indicating a low overall clinical strength (Level D). No human clinical trials were provided.

PubMed sources

1.PMID: 35844107 (2023) — Sakuranetin and its therapeutic potentials - a comprehensive review. · Zeitschrift fur Naturforschung. C, Journal of biosciences
2.PMID: 30551444 (2019) — Artemisia campestris L.: review on taxonomical aspects, cytogeography, biological activities and bioactive compounds. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
3.PMID: 17396957 (1982) — [Flavonoids of Artemisia campestris, ssp. glutinosa]. · Planta medica
4.PMID: 36575835 (2022) — Antioxidant Activity and Inhibition of Carbohydrate Digestive Enzymes Activities of Artemisia campestris L. · Frontiers in bioscience (Scholar edition)
5.PMID: 39037595 (2024)

Artemisia campestris

Sources & Citations

Thai Basil

Seseli libanotis

Artemisia nilagirica

Summary

Background

Traditional uses

Active compounds

Mechanism of action

Clinical evidence

Safety & adverse effects

Evidence summary

PubMed sources

Government sources

Artemisia campestris

Sources & Citations

Related Herbs

Thai Basil

Seseli libanotis

Artemisia nilagirica

Summary

Background

Traditional uses

Active compounds

Mechanism of action

Clinical evidence

Safety & adverse effects

Evidence summary

PubMed sources

Government sources